Novel PET Tracer for Perfusion Imaging: What's the Promise?

Flurpiridaz has potential cost, convenience and ― especially for women and obese patients ― efficacy advantages over current PET perfusion methods.

Related Keywords

California ,United States ,Canada ,Stanford University ,Denmark ,Boston ,Massachusetts ,Tufts University ,American ,Jamiesonm Bourque ,Michael Salerno ,Jamese Udelson ,Ge Healthcare ,Division Of Cardiology ,American Society Of Nuclear Cardiology ,Journal Of The American College Cardiology ,American College Of Cardiology Imaging Council ,University Of Virginia ,Drug Administration ,Society Of Nuclear Medicine ,American Society ,Nuclear Cardiology ,Nuclear Medicine ,Molecular Imaging ,American College ,Imaging Council ,Stress Laboratory ,Nuclear Cardiology Laboratory ,Tufts University School ,Cv ,Ardiovascular ,Cardiovascular Imaging ,Ardiac Imaging ,V Imaging ,Perfusion Imaging ,Atherosclerotic Heart Disease ,Therosclerotic Cardiovascular Disease ,Oronary Heart Disease ,Schemic Heart Disease ,Arteries ,Restenosis ,Athologic Constriction ,Stress ,Obesity ,Bese ,Blood ,Boards ,Smle ,Echocardiography ,Echocardiogram ,Echo ,Exercise ,Physical Activity ,Investment ,Leukemia ,Positron Emission T ,